Balance strategy in hoverboard control.

This study examines how people learn to perform lower limb control in a novel task with a hoverboard requiring to maintain dynamic balance. We designed an experiment to investigate the learning of hoverboard balance and two control strategies: A hip strategy, which mainly uses hip movements to change the angle of the foot, and an ankle strategy relying more on ankle motion to control the orientation of hoverboard plates controlling the motion. Motor learning was indicated by a significant [Formula: see text]% decrease in the trial completion time (p < 0.001) and a significant 24 ± 11% decrease in total muscle activation (p < 0.001). Furthermore, the participants, who had no prior experience riding a hoverboard, learned an ankle strategy to maintain their balance and control the hoverboard. This is supported by significantly stronger cross-correlation, phase synchrony, lower dynamic time warping distance between the hoverboard plate orientation controlling hoverboard motion, and the ankle angle when compared to the hip angle. The adopted ankle strategy was found to be robust to the foot orientation despite salient changes in muscle group activation patterns. Comparison with results of an experienced hoverboard rider confirmed that the first-time riders adopted an ankle strategy

Nitric oxide in the nucleus raphe magnus modulates cutaneous blood flow in rats during hypothermia

Objective(s): Nucleus Raphe Magnus (NRM) that is involved in the regulation of body temperature contains nitric oxide (NO) synthase. Considering the effect of NO on skin blood flow control, in this study, we assessed its thermoregulatory role within the raphe magnus. Materials and Methods: To this end, tail blood flow of male Wistar rats was measured by laser doppler following the induction of hypothermia. Results: Intra�NRM injection of SNP (exogenous NO donor, 0.1� 0.2 μl, 0.2 nM) increased the blood flow. Similarly, unilateral microinjection of glutamate (0.1� 0.2 μl, 2.3 nM) into the nucleus increased the blood flow. This effect of L�glutamate was reduced by prior intra NRM administration of NO synthase inhibitor NG�methyl�L�arginine or NG�nitro�L�arginine methyl ester (L�NAME, 0.1 μl, 100 nM). Conclusion: It is concluded that NO modulates the thermoregulatory response of NRM to hypothermia and may interact with excitatory amino acids in central skin blood flow regulation. © 2015, Mashhad University of Medical Sciences. All rights reserved

Design and test of a MEMS strain-sensing device for monitoring artificial knee implants

This paper describes the development of a polyimide-based MEMS strain-sensing device. Finite element analysis was used to investigate an artificial knee implant and assist on device design and to optimize sensing characteristics. The sensing element of the device was fabricated using polyimide micromachining with embedded thin-metallic wires and placed into a knee prosthesis. The device was evaluated experimentally in a mechanical knee simulator using static and dynamic axial load conditions similar to those encountered in vivo. Results indicates the sensor is capable of measuring the strain associated to the total axial forces in the range of approximately 4 times body weight with a good sensitivity and accuracy for events happening within 1 s time windo

Energy expenditure estimation using accelerometry and heart rate for multiple sclerosis and healthy older adults

Accurate estimation of Energy Expenditure (EE) in ambulatory settings provides greater insight into the underlying relation between different human physical activity and health. This paper describes the development and validation of energy expenditure estimation algorithms. A total of 4 healthy subjects and 3 suffering from multiple sclerosis were monitored using a gold-standard energy expenditure measurement system, a heart rate monitor and accelerometry. We demonstrated that greater improvements can be achieved by estimating energy expenditure during normal activities of daily living by combining both whole body acceleration estimates, vertical body acceleration estimates, body posture and heart rate data as part of a flex heart rate algorithm in subject specific models when compared to using accelerometry or heart rate data alone. This will allow more accurate EE estimation during normal activities of daily living

Photodegradation of Pollutants in Air: Enhanced Properties of Nano-TiO2Prepared by Ultrasound

Nanocrystalline TiO2samples were prepared by promoting the growth of a sol–gel precursor, in the presence of water, under continuous (CW), or pulsed (PW) ultrasound. All the samples turned out to be made of both anatase and brookite polymorphs. Pulsed US treatments determine an increase in the sample surface area and a decrease of the crystallite size, that is also accompanied by a more ordered crystalline structure and the samples appear to be more regular and can be considered to contain a relatively low concentration of lattice defects. These features result in a lower recombination rate between electrons and holes and, therefore, in a good photocatalytic performance toward the degradation of NOxin air. The continuous mode induces, instead, the formation of surface defects (two components are present in XPS Ti 2p3/2region) and consequently yields the best photocatalyst. The analysis of all the characterization data seems to suggest that the relevant parameter imposing the final features of the oxides is the ultrasound total energypervolume (Etot/V) and not the acoustic intensity or the pulsed/continuous mode

Ruxolitinib versus best available therapy for polycythemia vera intolerant or resistant to hydroxycarbamide in a randomized trial

Purpose Polycythemia vera (PV) is characterized by JAK/STAT activation, thrombotic/hemorrhagic events, systemic symptoms, and disease transformation. In high-risk PV, ruxolitinib controls blood counts and improves symptoms. Patients and Methods MAJIC-PV is a randomized phase II trial of ruxolitinib versus best available therapy (BAT) in patients resistant/intolerant to hydroxycarbamide (HC-INT/RES). Primary outcome was complete response (CR) within 1 year. Secondary outcomes included duration of response, event-free survival (EFS), symptom, and molecular response. Results One hundred eighty patients were randomly assigned. CR was achieved in 40 (43%) patients on ruxolitinib versus 23 (26%) on BAT (odds ratio, 2.12; 90% CI, 1.25 to 3.60; P = .02). Duration of CR was superior for ruxolitinib (hazard ratio [HR], 0.38; 95% CI, 0.24 to 0.61; P < .001). Symptom responses were better with ruxolitinib and durable. EFS (major thrombosis, hemorrhage, transformation, and death) was superior for patients attaining CR within 1 year (HR, 0.41; 95% CI, 0.21 to 0.78; P = .01); and those on ruxolitinib (HR, 0.58; 95% CI, 0.35 to 0.94; P = .03). Serial analysis of JAK2V617F variant allele fraction revealed molecular response was more frequent with ruxolitinib and was associated with improved outcomes (progression-free survival [PFS] P = .001, EFS P = .001, overall survival P = .01) and clearance of JAK2V617F stem/progenitor cells. ASXL1 mutations predicted for adverse EFS (HR, 3.02; 95% CI, 1.47 to 6.17; P = .003). The safety profile of ruxolitinib was as previously reported. Conclusion The MAJIC-PV study demonstrates ruxolitinib treatment benefits HC-INT/RES PV patients with superior CR, and EFS as well as molecular response; importantly also demonstrating for the first time, to our knowledge, that molecular response is linked to EFS, PFS, and OS

Enzymatic processing of protein-based fibers

Wool and silk are major protein fiber materials used by the textile industry. Fiber protein structure-function relationships are briefly described here, and the major enzymatic processing routes for textiles and other novel applications are deeply reviewed. Fiber biomodification is described here with various classes of enzymes such as protease, transglutaminase, tyrosinase, and laccase. It is expected that the reader will get a perspective on the research done as a basis for new applications in other areas such as cosmetics and pharma.This work was financially supported by the National Natural Science Foundation of China (21274055,51373071, 31201134 and 31470509), the Program for New Century Excellent Talents in University (NCET-12-0883), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1135), the Jiangsu Provincial Natural Science Foundation of China (BK2012112), and the Fundamental Research Funds for the Central Universities (JUSRP51312B)

Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm

Funder: Cancer Research UK (CRUK); doi: https://doi.org/10.13039/501100000289Funder: DH | National Institute for Health Research (NIHR); doi: https://doi.org/10.13039/50110000027